MiNK Therapeutics INKT Cash Flow Statement (2020-2026)

NASDAQ INKT
$11.62 +0.27 (+2.38%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-21.45M-7.17M-13.13M-10.96M-12.65M-7.90M-9.90M-10.81M-7.53M-5.45M-3.79M-5.11M-3.29M-2.51M-2.63M-5.41M-9.32M-2.45M-2.79M-7.47M
Depreciation and Depletion (Quarter)
0.02M0.02M0.03M0.03M0.03M0.04M0.05M0.05M0.05M0.05M0.05M0.05M0.06M0.05M0.05M0.05M0.04M0.04M0.04M0.04M
Share-based Compensation (Quarter)
0.39M0.67M0.04M0.00M0.03M-0.20M0.03M0.03M0.03M1.10M0.03M0.03M0.88M-2.35M0.57M0.01M0.80M0.59M0.63M1.40M
Cash from Operations (Quarter)
-3.50M-1.70M-4.20M-4.63M-5.61M-4.43M-4.37M-4.15M-4.21M-3.04M-2.54M-2.29M-2.99M-1.73M-1.34M-1.57M-0.94M-2.07M-1.73M-2.08M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.02M0.02M0.03M0.03M0.03M0.04M0.05M0.05M0.05M0.05M0.05M0.05M0.06M0.05M0.05M0.05M0.04M0.04M0.04M0.04M
Change in Working Capital
Change in Account Payables (Quarter)
-0.61M1.35M0.64M0.97M0.48M0.57M0.15M-1.12M-0.58M-0.37M-0.42M-0.28M-0.85M0.37M-0.07M0.65M0.38M-0.27M-0.03M0.53M
Change in Accured Expenses (Quarter)
0.64M-1.30M1.19M0.37M0.00M1.86M-0.55M1.70M-0.39M1.26M0.32M-0.28M0.35M-0.78M0.10M-0.02M0.05M0.58M0.21M-0.25M
Other Working Capital Changes (Quarter)
-0.43M-3.26M-1.12M-2.03M0.41M-0.24M-0.76M-0.74M-0.66M-0.39M-0.73M-0.52M-0.58M-0.40M-0.55M-0.58M-0.61M-0.18M-0.16M-0.32M
Investing Activities
Capital Expenditures (Quarter)
0.11M-277.000.06M0.13M0.01M0.04M0.02M
Cash from Investing Activities (Quarter)
-0.11M277.00-0.06M-0.13M-0.01M-0.04M-0.02M
Financing Activities
Other financing activities (Quarter)
39.80M689.00301.00494.00111.00
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
5.00M5.00M
Change in Capital Stock
Shares Issued (Quarter)
4.91M4.87M2.57M6.40M6.24M6.15M6.72M6.83M3.89M0.69M8.25M8.99M8.95M0.90M0.88M0.86M0.77M0.88M0.64M0.90M
Net Equity Issued and Repurchased (Quarter)
1.32M3.02M1.37M
Misc.
Cash from Financing Activities (Quarter)
2.78M39.80M689.00-0.16M494.00111.00-0.33M-0.08M0.00M-2.005.01M5.81M0.01M-3.00576.00540.0013.55M1.18M-2.10M1.37M
Exchange Rate Effect (Quarter)
-0.01M-0.03M-0.00M0.00M-0.01M0.04M-0.03M-0.01M0.01M0.00M-0.01M-0.02M0.00M-0.02M-0.00M0.02M-0.01M-0.02M-0.00M-0.00M
Change in Cash (Quarter)
-0.84M38.07M-4.20M-4.84M-5.69M-4.52M-4.74M-4.27M-4.22M-3.03M2.45M3.50M-2.99M-1.75M-1.34M-1.55M12.60M-0.92M-3.83M-0.72M
Free Cash Flow (Quarter)
-3.61M-1.70M-4.20M-4.63M-5.67M-4.56M-4.38M-4.19M-4.23M-3.04M-2.54M-2.29M-2.99M-1.73M-1.34M-1.57M-0.94M-2.07M-1.73M-2.08M
Net Cash Flow (Quarter)
-0.82M38.10M-4.20M-4.78M-5.67M-4.56M-4.71M-4.26M-4.23M-3.04M2.46M3.52M-2.99M-1.73M-1.34M-1.57M12.60M-0.90M-3.83M-0.72M